m+Medelevator.RU
← Поиск публикаций
Retinal cases & brief reports · 2025

TREATMENT OF NOCARDIA CHORIORETINITIS-RELATED CHOROIDAL NEOVASCULARIZATION WITH AFLIBERCEPT: A CASE OF UNVEILED IMMUNOCOMPROMISE WITH ANTI-GM-CSF ANTIBODIES.

СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Korot Edward, Jaje Katherine E, Singhal Neena, Miglio Maria C

Аннотация

PURPOSE: The purpose of this study was to describe a case of Nocardia chorioretinitis-related choroidal neovascularization in a patient with anti-GM-CSF antibodies with resolution of choroidal neovascularization and visual recovery after a series of intravitreal anti-vascular endothelial growth factor.

METHODS: This study is a case report.

RESULTS: In this case, a 50-year-old woman, thought to be immunocompetent, presented with metamorphopsia and decreased visual acuity in the left eye in the setting of disseminated nocardiosis . She had evidence of a subfoveal Nocardia lesion with subretinal fluid and choroidal neovascularization. After a series of off-label injections with aflibercept, the patient had improvement in lesion size, exudation, and visual acuity. Extensive workup yielded underlying immunocompromise because of the presence of anti-GM-CSF antibodies, likely predisposing her to disseminated Nocardiosis.

CONCLUSION: The use of aflibercept in Nocardia chorioretinitis led to resolution of neovascular activity with visual recovery in a patient with disseminated Nocardiosis.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты